LIGAND PHARMACEUTICALS INCORPORATED Deferred Tax Assets, Net
LIGAND PHARMACEUTICALS INCORPORATED (LGNDZ) had Deferred Tax Assets, Net of $4.87 million as of 2021-12-31, per its 10-K filed 2023-02-28.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net
us-gaap:DeferredTaxAssetsLiabilitiesNet · last filed 2023-02-28
- 2021-12-31: Deferred Tax Assets, Net $4.87M.
- 2018-12-31: Deferred Tax Assets, Net $46.52M.
- 2017-12-31: Deferred Tax Assets, Net $84.42M.
- 2016-12-31: Deferred Tax Assets, Net $123.89M.
| Period end | Deferred Tax Assets, Net | Deferred Tax Assets, Net as first filed |
|---|---|---|
| 2021-12-31 | $4.87M 10-K · filed 2023-02-28 | |
| 2018-12-31 | $46.52M 10-K · filed 2020-02-27 | |
| 2017-12-31 | $84.42M 10-K · filed 2019-02-28 | |
| 2016-12-31 | $123.89M 10-K · filed 2018-03-01 | |
| 2015-12-31 | $189.08M 10-K · filed 2017-02-28 | $216.56M 10-K · filed 2016-02-26 |